Articles tagged with Cannabinoids
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found an enzymatic pathway that converts omega-3-derived endocannabinoids into potent anti-inflammatory molecules, which bind to receptors in the immune system. This discovery demonstrates how omega-3 fatty acids can produce medicinal qualities similar to marijuana without a psychotropic effect.
A commentary in CMAJ argues that a two-streamed structure is necessary to keep patients safe and support research into the therapeutic effects of cannabinoids. This structure would provide incentives for research, educational resources for healthcare practitioners, and reduce risk to patients.
A special issue of Epilepsy & Behavior evaluates the benefits of medical marijuana for treating epilepsy, highlighting gaps in knowledge and education. Key findings include anecdotal data on cannabis use for epilepsy treatment and potential effects on brain function.
A new mass spectrometry-based screening method enables quick turnaround of drug screens and can be used in emergency rooms to detect lethal compounds. The low-cost cartridges are estimated to cost less than $10 each, making them accessible to health facilities of any size.
Researchers found that low-dose cannabis can reverse cognitive decline in older mice by increasing nerve cell connections and reversing molecular signatures. This breakthrough opens the door to potential human clinical trials for treating age-related dementia.
New research examines how genetics contribute to the metabolism of synthetic cannabinoids, increasing risk for severe effects. Understanding this connection could lead to targeted treatments and antidotes.
Researchers discovered that capsaicin in chili peppers and anandamide in marijuana interact with the same receptor in the stomach, calming the immune system and reducing inflammation. The study holds promise for new therapies for diabetes and colitis, as well as understanding the relationship between the gut, brain, and immune system.
Researchers at CU Anschutz Medical Campus found that cannabinoids may be effective in treating eczema, psoriasis, and other skin diseases. Topical cannabinoid drugs with little psychotropic effect could provide relief for patients with itchy skin conditions.
A Vanderbilt study found that increasing the supply of a natural chemical called 2-arachidonoylglycerol (2-AG) in the brain promotes resilience to acute stress exposure. The study suggests that boosting this signaling system could represent a new treatment approach for mood and anxiety disorders, including PTSD.
A prospective study found that symptoms of depression, drinking alcohol, or using marijuana increased the risk of synthetic marijuana (SC) use one year later. SCs are potent chemicals similar to THC, often sold as potpourri or incense and appealing to adolescents due to ease of access and affordability.
Researchers found synthetic marijuana compounds are chemically distinct from marijuana, activate different receptors, and pose health risks. Studies reported acute and long-term adverse effects, including seizures, psychosis, dependence, and death.
Research suggests that cannabinoids in medical marijuana could alleviate heroin withdrawal symptoms and cravings. A specific compound, cannabidiol, shows promise in reducing anxiety related to cravings and restoring neurobiological damage.
Researchers have identified a non-addictive pathway to pain relief by targeting endocannabinoid receptors in the brain. The study suggests that selective activation of CB2 receptors can contribute to the medicinal benefits of cannabis while minimizing the risk of tolerance and withdrawal.
A study by UC Riverside researchers shows that a western diet leads to overeating and obesity due to elevated peripheral endocannabinoid signaling. This therapeutic approach targets cannabinoid receptors in the periphery, holding promise as a safe treatment for overeating and diet-induced obesity.
Researchers at Osaka University discovered that retraction of early thalamocortical connections, driven by cannabinoids, can help form L4-L2/3 connections. This finding may contribute to understanding neuronal circuit mechanisms and prevention of cannabis abuse.
A new study found that only 20% of cannabis dispensary staff have medical or scientific training, despite recommending treatments to patients. The lack of training is concerning, as some recommendations may be ineffective and worsen patient conditions.
A study found that cannabis users in Australia recommended package warnings that focused on driving ability, mental health, and addiction risk, mirroring some expert warnings. However, users also suggested unconventional warnings not typically recommended by experts, highlighting the need for caution in packaging cannabis products.
Researchers at UT Southwestern Medical Center have reported a high-resolution structure of the human cannabinoid receptor 1 (CB1), which binds to tetrahydrocannabinol (THC) and is responsible for marijuana's high. This detailed structure should lead to a better understanding of how cannabinoids initiate signals in the brain.
Researchers found that cannabinoids inhibit neurotransmitter release and reduce mitochondrial energy, leading to memory loss. The study suggests a new therapeutic approach by targeting specific CB1 receptors in the brain.
A new study reveals the detailed structure of the human CB1 receptor, a key target for cannabinoids. The findings provide clues to mechanisms by which certain chemicals produce longer-lasting effects and offer guidance for designing novel medications that specifically target portions of the receptor.
The study provides a three-dimensional image of cannabinoid receptor 1, which is found to be embedded in the surface of many nerve cells. This discovery could explain how pain medications meant to mimic cannabis use without the 'high' can cause unintended side effects.
A team of biologists has identified a cannabinoid receptor, GPR18, in spermatozoa that plays a crucial role in the acrosome reaction and fertilization process. The receptor is sensitive to NAGly and THC, and its activation triggers the acrosome reaction.
Researchers found that activating cannabinoid signaling increases activity in retinal ganglion cells, allowing tadpoles to detect dimmer objects in low light. This discovery challenges previous understanding of cannabinoids' role in vision and provides a potential mechanism for their therapeutic use.
A new study suggests that oral cannabidiol may convert to the psychoactive compound THC in the stomach, potentially leading to adverse effects. The research found that gastric fluids can convert CBD into THC, which could explain why some children treated with CBD for epilepsy experienced unexpectedly high rates of sleepiness and fatigue.
The Journal announces a new collaboration with IACM to increase published clinical research on clinical cannabis, cannabinoids, and the endocannabinoid system. The partnership aims to further the science of clinical cannabis for potential therapeutic applications.
A growing body of evidence suggests that cannabinoids have therapeutic potential for treating various conditions, including Parkinson's disease and gastrointestinal illnesses. The development of new pain therapies is crucial due to demographic changes and increasing life expectancy, which will lead to more patients with chronic pain.
Researchers found that the CB2 receptor regulates nerve cell activity in the hippocampus, adjusting communication processes. The discovery could lead to novel medications for schizophrenia, depression, and Alzheimer's disease.
A roundtable discussion explores the addictive potential of cannabis, its symptoms, risks, and health consequences. The discussion also examines current research efforts to identify effective treatments for cannabis addiction and ongoing clinical trials testing investigational agents.
A recent French study found that a drug tested on paid volunteers resulted in one death and five hospitalizations but did not contain cannabis or cannabinoids. The drug, an FAAH inhibitor, may have interacted with another protein responsible for the toxicity.
A new review found scant scientific evidence supporting cannabinoid use in rheumatic diseases, citing only four small studies with limited information. Rheumatologists cannot recommend cannabinoids as a therapeutic option due to high side effects and limited long-term efficacy data.
Scientists discovered that cannabinoid receptors in the brain exclusively control aversive memories, excluding neutral and positive ones. This finding has significant implications for treating diseases associated with emotional processes like depression and anxiety.
Researchers found that THC delayed skin graft rejection in mice due to suppressed immune response, potentially leading to new antirejection therapies for humans. Further studies are necessary to confirm benefits in humans.
A review of 79 randomized trials involving 6,500 participants found moderate-quality evidence supporting the use of cannabinoids for chronic pain and lower-quality evidence for nausea and vomiting. However, the effectiveness of cannabis for other conditions remains unclear, with increased risk of adverse effects.
Research in The FASEB Journal suggests that fenofibrate may become a viable treatment option for relieving pain, stimulating appetite, reducing nausea, and preventing depression. The study found that fenofibrate activates cannabinoid receptors, which could lead to the development of new drugs targeting these receptors.
A Vanderbilt University study suggests replenishing 2-AG levels in the brain could alleviate mood and anxiety disorders. By restoring normal levels of 2-AG, researchers may have found a potential therapeutic strategy for treating depression and anxiety.
Researchers found that anandamide, a cannabinoid compound, directly causes Ca2+ influx and triggers an increase in intracellular Ca2+ concentration. The study discovered two independent mechanisms involving protein kinase C signaling pathway for anandamide's inhibitory effects on voltage-gated calcium channels.
Researchers identify cannabinoid receptors in the central nucleus of the amygdala, a key emotional hub involved in regulating anxiety and stress responses. The discovery may help explain why marijuana users take the drug to reduce anxiety.
Researchers discovered that CB1 cannabinoid receptors control a circuit connecting the olfactory bulb to the olfactory cortex, increasing sensitivity to smell during hunger. This biological mechanism may be altered in obese or anorexic patients, enabling better management of these pathologies.
Researchers found that cortical type 2 cannabinoid receptor (CB2R) agonist trans-caryophyllene protected brain cells from ischemic effects. TC decreased cerebral infarct size and edema in animal models, with effects reversed by CB2R antagonist AM630.
Researchers report on cannabinoid hyperemesis syndrome (CH), a little-known but costly effect of marijuana use, characterized by cyclic nausea, vomiting, and abdominal pain. CH can lead to expensive diagnostic tests and ineffective treatments, with some patients requiring multiple hospital visits and costing up to $30,000 in workups.
Researchers from the University of Saskatchewan have discovered the chemical pathway used by cannabis to produce bioactive compounds called cannabinoids. This breakthrough could lead to the development of marijuana varieties for pharmaceutical use or cannabinoid-free industrial hemp.
A study in rats found that adolescent female rats exposed to marijuana-like cannabinoids through their mothers had a higher preference for morphine, suggesting increased risk of drug abuse in their male offspring. The findings support earlier reports on the negative effects of prenatal cannabinoid exposure on development and behavior.
Researchers at UCI found that blocking an endocannabinoid compound called 2-AG boosts fat burning and leads to weight loss in mice. The study suggests that this natural chemical plays a critical role in energy metabolism, and blocking its production may lead to new treatments for obesity.
Researchers have identified a mechanism by which cannabinoids in cannabis affect working memory, involving decreased neural connections in the hippocampus. Cannabinoid receptors, particularly those in astroglial cells, modulate synaptic plasticity and impair spatial working memory.
Researchers found a link between genetic variants in cannabinoid receptor 1 (CNR1) and increased susceptibility to alcohol dependence. Specific CNR1 polymorphisms were more frequent in patients with alcohol dependence than those who abused alcohol.
Scientists have created new tests to identify the source of emerging designer drugs, such as 'bath salts' and synthetic cannabinoids. The tests use isotope ratio mass spectrometry (IRMS) to trace the production of these substances, which can cause euphoria, paranoia, and hallucinations.
Researchers used molecular imaging to visualize changes in the brains of heavy marijuana smokers versus non-smokers, finding a decreased number of cannabinoid CB1 receptors. Chronic cannabis smoking caused downregulation of these receptors, but they returned to normal when subjects stopped smoking.
A recent study by University of Western Ontario researchers has identified a critical brain pathway responsible for the effects of cannabinoid drugs on emotional processing. The findings suggest that activating cannabinoid receptors in the amygdala region can significantly impact emotional information and memory processes.
Researchers found that omega-3 deficient mice exhibited disturbed synaptic functions and emotional behaviors, including depression. The study suggests that chronic malnutrition during intrauterine development may influence synaptic activity involved in emotional behavior in adulthood.
Researchers have found that boosting brain levels of 2-AG, a natural painkiller, soon leads to loss of its therapeutic effect due to receptor downregulation. This discovery has implications for drug development and basic science, suggesting that more modest elevations in 2-AG may produce sustained pain relief.
A $4 million grant will be used to investigate the effects of THC on HIV, with a focus on anti-inflammatory and viral suppression mechanisms. The research aims to develop targeted therapeutic interventions to improve HIV disease progression.
Research suggests that THC induces autophagy-mediated cell death in human brain cancer cells, including glioblastoma multiforme. Administration of THC to mice with human tumors decreased tumor growth and induced autophagy in tumor cells.
Scripps researchers develop first definitive study of 2-AG's activity after discovering MAGL-specific inhibitor JZL184, reducing pain in mice and inducing effects associated with cannabinoid receptors. This breakthrough could lead to new treatments for chronic pain, obesity, anxiety, and depression.
A study published in Cancer Research found that the CB1 receptor plays a tumor-suppressing role in human colorectal cancer. Researchers discovered that CB1 expression is lost in most colorectal cancers, leading to increased tumor growth. Restoring CB1 expression with an existing drug showed promise in reducing tumors.
Researchers are investigating new strategies for targeting the endocannabinoid system, which plays a role in pain relief and treating conditions like obesity and nicotine addiction. These studies aim to develop new drugs that can selectively target cannabinoid receptors without causing psychoactive side effects.
Researchers found an 86% increase in non-serious adverse events among patients treated with cannabinoids, mainly affecting the nervous system. Cannabinoids are used to treat chronic pain and stimulate appetite, but physicians must weigh benefits against possible side effects.
A systematic review found short-term medical cannabinoid use linked to higher rates of non-serious adverse events, particularly dizziness. However, longer-term effects in chronic illness remain unexplored.
A new study from the University of Minnesota has identified a key receptor molecule involved in the development of sun-induced skin cancer. Researchers found that UV light triggers this molecule to change state, allowing it to interact with cannabinoid compounds found in marijuana, leading to an increased risk of skin cancer.
A new MIT study found that a class of anti-obesity drugs could interfere with neural development in young children by blocking brain receptors similar to those in marijuana. The research, conducted on mice, suggests caution when using these compounds in kids.
Researchers discovered that astrocytes play a crucial role in cannabinoid signaling, interacting with neurons through endocannabinoid-glutamate signaling. This finding may lead to the development of new treatments for cannabinoid-related drug abuse.